Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dorte Vistisen

Showing results (1-10 of 125) with videos related to

Pageof 13
Sort By:
Diabetes Care|December 25, 2012
Comment on: Tam et al. Defining insulin resistance from hyperinsulinemic-euglycemic clamps. Diabetes Care 2012;35:1605-1610Kristine Færch, Dorte Vistisen
JAMA|January 9, 2014
Prevalence of diabetes in Chinese adultsKristine Færch, Dorte Vistisen
BMJ (Clinical Research Ed.)|February 26, 2017
Is there a need for new diabetes prevention trials?Kristine Færch, Dorte Vistisen
Diabetologia|October 4, 2014
Eighteen year weight trajectories and metabolic markers of diabetes in modernising China: which timescale is most relevant?Dorte Vistisen, Kristine Færch
Diabetes Care|December 17, 2008
Bimodal distribution of glucose is not universally useful for diagnosing diabetesDorte Vistisen, Stephen Colagiuri, Knut Borch-Johnsen, et al.
Diabetologia|July 28, 2023
Glycaemic control, risk of hypoglycaemia and all-cause mortality in new users of second-generation basal insulin with type 2 diabetes and chronic kidney disease: a nationwide register-based cohort studyVanja Kosjerina, Bendix Carstensen, Hanan Amadid, et al.
Diabetes Care|January 31, 2006
Risk scores for type 2 diabetes can be applied in some populations but not allCharlotte Glümer, Dorte Vistisen, Knut Borch-Johnsen, et al.
Clinical Endocrinology|August 24, 2017
Assessment of time to glucose peak during an oral glucose tolerance testAdam Hulman, Daniel R Witte, Dorte Vistisen, et al.
Plos One|September 26, 2014
Reduction of specific circulating lymphocyte populations with metabolic risk factors in patients at risk to develop type 2 diabetesHelena Cucak, Dorte Vistisen, Daniel Witte, et al.
Current Diabetes Reports|April 19, 2014
Cardiovascular risk stratification and management in pre-diabetesKristine Færch, Dorte Vistisen, Nanna Borup Johansen, et al.
Pageof 13

Showing results (1-10 of 125) with videos related to

Sort By:
Pageof 13
Diabetes Care|December 25, 2012
Comment on: Tam et al. Defining insulin resistance from hyperinsulinemic-euglycemic clamps. Diabetes Care 2012;35:1605-1610Kristine Færch, Dorte Vistisen
JAMA|January 9, 2014
Prevalence of diabetes in Chinese adultsKristine Færch, Dorte Vistisen
BMJ (Clinical Research Ed.)|February 26, 2017
Is there a need for new diabetes prevention trials?Kristine Færch, Dorte Vistisen
Diabetologia|October 4, 2014
Eighteen year weight trajectories and metabolic markers of diabetes in modernising China: which timescale is most relevant?Dorte Vistisen, Kristine Færch
Diabetes Care|December 17, 2008
Bimodal distribution of glucose is not universally useful for diagnosing diabetesDorte Vistisen, Stephen Colagiuri, Knut Borch-Johnsen, et al.
Diabetologia|July 28, 2023
Glycaemic control, risk of hypoglycaemia and all-cause mortality in new users of second-generation basal insulin with type 2 diabetes and chronic kidney disease: a nationwide register-based cohort studyVanja Kosjerina, Bendix Carstensen, Hanan Amadid, et al.
Diabetes Care|January 31, 2006
Risk scores for type 2 diabetes can be applied in some populations but not allCharlotte Glümer, Dorte Vistisen, Knut Borch-Johnsen, et al.
Clinical Endocrinology|August 24, 2017
Assessment of time to glucose peak during an oral glucose tolerance testAdam Hulman, Daniel R Witte, Dorte Vistisen, et al.
Plos One|September 26, 2014
Reduction of specific circulating lymphocyte populations with metabolic risk factors in patients at risk to develop type 2 diabetesHelena Cucak, Dorte Vistisen, Daniel Witte, et al.
Current Diabetes Reports|April 19, 2014
Cardiovascular risk stratification and management in pre-diabetesKristine Færch, Dorte Vistisen, Nanna Borup Johansen, et al.
Pageof 13